ART - antiretroviral therapy
ICAP Key Contributor to WHO Toolkit for Development of Pediatric Antiretroviral Drugs
ICAP was a key contributor to the “Toolkit for Research and Development of Paediatric Antiretroviral Drugs and Formulations” recently launched by the World Health Organization (WHO). Developed under the umbrella of the Global Accelerator for Paediatric Formulations...
(ASPPH Friday Letter) ICAP Pioneers PrEP in Democratic Republic of Congo
Something revolutionary in HIV prevention is happening in Central Africa. Pre-exposure prophylaxis (PrEP) is being implemented for the first time in the Democratic Republic of Congo (DRC). People at on-going, substantial risk of HIV infection are offered PrEP — the...
New Study First to Estimate Time Spent on Cardiovascular Disease Screening within HIV Services
A pioneering study by researchers from ICAP at Columbia University’s Mailman School of Public Health identified key challenges to integrating cardiovascular disease risk factor (CVDRF) screening into HIV clinic visits in low-resource settings. The report, titled “A...

